DOCSLIB.ORG

Muscle Fatigue and Muscle Weakness: What We Know and What We Wish We Did

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Muscle Fatigue and Muscle Weakness: What We Know and What We Wish We Did MUSCLE FATIGUE AND MUSCLE WEAKNESS: WHAT WE KNOW AND WHAT WE WISH WE DID Topic Editors P. Bryant Chase and Christina Karatzaferi PHYSIOLOGY FRONTIERS COPYRIGHT STATEMENT ABOUT FRONTIERS © Copyright 2007-2013 Frontiers is more than just an open-access publisher of scholarly articles: it is a pioneering Frontiers Media SA. All rights reserved. approach to the world of academia, radically improving the way scholarly research is managed. All content included on this site, The grand vision of Frontiers is a world where all people have an equal opportunity to seek, share such as text, graphics, logos, button and generate knowledge. Frontiers provides immediate and permanent online open access to all icons, images, video/audio clips, downloads, data compilations and its publications, but this alone is not enough to realize our grand goals. software, is the property of or is licensed to Frontiers Media SA (“Frontiers”) or its licensees and/or subcontractors. The copyright in the FRONTIERS JOURNAL SERIES text of individual articles is the property of their respective authors, The Frontiers Journal Series is a multi-tier and interdisciplinary set of open-access, online subject to a license granted to Frontiers. journals, promising a paradigm shift from the current review, selection and dissemination The compilation of articles processes in academic publishing. constituting this e-book, as well as All Frontiers journals are driven by researchers for researchers; therefore, they constitute a service all content on this site is the exclusive property of Frontiers. to the scholarly community. At the same time, the Frontiers Journal Series operates on a revo- Images and graphics not forming lutionary invention, the tiered publishing system, initially addressing specific communities of part of user-contributed materials may not be downloaded or copied scholars, and gradually climbing up to broader public understanding, thus serving the interests without permission. of the lay society, too. Articles and other user-contributed materials may be downloaded and reproduced subject to any copyright or other notices. No financial DEDICATION TO QUALITY payment or reward may be given for any such reproduction except to the Each Frontiers article is a landmark of the highest quality, thanks to genuinely collaborative interac- author(s) of the article concerned. tions between authors and review editors, who include some of the world’s best academicians. As author or other contributor you grant permission to others to Research must be certified by peers before entering a stream of knowledge that may eventually reproduce your articles, including reach the public - and shape society; therefore, Frontiers only applies the most rigorous and any graphics and third-party materials supplied by you, in unbiased reviews. accordance with the Conditions for Frontiers revolutionizes research publishing by freely delivering the most outstanding research, Website Use and subject to any copyright notices which you include evaluated with no bias from both the academic and social point of view. in connection with your articles and By applying the most advanced information technologies, Frontiers is catapulting scholarly materials. publishing into a new generation. All copyright, and all rights therein, are protected by national and international copyright laws. The above represents a summary only. For the full conditions see the WHAT ARE FRONTIERS RESEARCH TOPICS? Conditions for Authors and the Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are Conditions for Website Use. collections of at least ten articles, all centered on a particular subject. With their unique mix Cover image provided by Ibbl sarl, Lausanne CH of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot ISSN 1664-8714 research area! ISBN 978-2-88919-163-5 Find out more on how to host your own Frontiers Research Topic or contribute to one as an DOI 10.3389/978-2-88919-163-5 author by contacting the Frontiers Editorial Office: [email protected] Frontiers in Physiology August 2013 | Muscle fatigue and muscle weakness: what we know and what we wish we did | 1 MUSCLE FATIGUE AND MUSCLE WEAKNESS: WHAT WE KNOW AND WHAT WE WISH WE DID Topic Editors: P. Bryant Chase, Florida State University, USA Christina Karatzaferi, University of Thessaly, Greece The purpose of this Research Topic is to discuss evidence coming from macroscopic observations on the whole human/animal to investigations at the molecular level in an effort to identify critical factors in muscle fatigue and muscle weakness, in health and disease. Why is this important? Skeletal muscles confer movement to the human body using vast amounts of energy provided through complex metabolic pathways. Thus, whole body mobility and energy balance are dictated by muscle Image by P. Bryant Chase and Christina contraction. On the other side, muscle Karatzaferi. function reflects overall health status, as chronic conditions and/or ageing affect either or both of muscle quality (protein and fat content) and quantity (mass). In health, muscle fatigue is temporary and recovery occurs rapidly. In ageing or chronic disease however, muscle fatigue may occur prematurely and be persistent, endangering thus a person’s safety (i.e. weakness leads to falls), and leading the sufferer in a self-perpetuating vicious cycle of inactivity -> disuse muscle atrophy/metabolic disturbance and so on, that compounds morbidity (i.e. causing metabolic syndrome, fatness, hypertension, muscle cachexia) and that eventually leads to premature death. Frontiers in Physiology August 2013 | Muscle fatigue and muscle weakness: what we know and what we wish we did | 2 Research in skeletal muscle physiology and biophysics is at an exciting phase. The advent of new methodologies and technological advancements have allowed researchers to advance our knowledge on the “how’s” and “why’s” of muscle contraction – however there are still many unanswered questions especially when disease states are implicated. Such questions need addressing if as a scientific community we aspire to secure better designed interventions to improve muscle function, and thus improve quality of life and life prognosis for the ageing population and chronic disease patients. Frontiers in Physiology August 2013 | Muscle fatigue and muscle weakness: what we know and what we wish we did | 3 Table of Contents 05 Muscle Fatigue and Muscle Weakness: What We Know and What We Wish We Did Christina Karatzaferi and P. Bryant Chase Mechanisms of Muscle Function at the Sarcomeric Level 08 Recent Insights Into Muscle Fatigue at the Cross-Bridge Level Edward P. Debold 22 The Multiple Roles of Phosphate in Muscle Fatigue David G. Allen and Sofie Trajanovska 30 The Sarcomeric Protein Nebulin: Another Multifunctional Giant in Charge of Muscle Strength Optimization Coen A. C. Ottenheijm, Henk Granzier and Siegfried Labeit Modeling Muscle Function 39 A Physiologically Based, Multi-Scale Model of Skeletal Muscle Structure and Function O. Röhrle, J. B. Davidson and A. J. Pullan Physical Activity and Exercise Performance 53 Effects of Physical Activity and Inactivity on Muscle Fatigue Gregory C. Bogdanis 68 Antioxidants and Skeletal Muscle Performance: “Common Knowledge” vs. Experimental Evidence Andrés Hernández, Arthur Cheng and Håkan Westerblad The Muscle-Brain Connection of Fatigue in Health and Disease 74 Muscle Fatigue and Cognition: What is the Link? Tali Kobilo and Henriette van Praag 77 Hemodialysis Fatigue: Just “Simple” Fatigue or A Syndrome on Its Own Right? Giorgos K. Sakkas and Christina Karatzaferi 81 Fatigue is a Brain-Derived Emotion That Regulates the Exercise Behavior to Ensure the Protection of Whole Body Homeostasis Timothy David Noakes Frontiers in Physiology August 2013 | Muscle fatigue and muscle weakness: what we know and what we wish we did | 4 EDITORIAL published: 30 May 2013 doi: 10.3389/fphys.2013.00125 Muscle fatigue and muscle weakness: what we know and what we wish we did Christina Karatzaferi 1,2* and P.Bryant Chase 3 1 Department of Physical Education and Sports Science, University of Thessaly, Trikala, Greece 2 Department of Kinesiology, Center for Research and Technology Thessaly, Trikala, Greece 3 Department of Biological Science, The Florida State University, Tallahassee, FL, USA *Correspondence: [email protected] Edited by: Peter J. Reiser, Ohio State University, USA Reviewed by: Peter J. Reiser, Ohio State University, USA This Research Topic on muscle fatigue and muscle weakness 1996; Karatzaferi et al., 2003, 2008). These effects may be due presents the latest ideas, arguments, and evidence from investi- to direct binding to proteins, or due to a more global alteration gations at the molecular level to macroscopic observations on of cellular energetics (GATP )inthemyocyte(Karatzaferi et al., whole animals including humans, in an effort to identify criti- 2004). cal factors underlying fatigue and weakness in health and disease. In this Research Topic, Debold (2012) consolidates the most Skeletal muscles confer movement to the human body using recent information, including single molecule assays and molec- vast amounts of energy provided through complex metabolic ular biological approaches, about the mechanisms by which Pi, pathways such that whole body mobility and energy balance H+, and ADP inhibit actomyosin cross-bridge
Load more

Recommended publications
  • Nebulette Is a Powerful Cytolinker Organizing Desmin and Actin in Mouse Hearts
    M BoC | ARTICLE Nebulette is a powerful cytolinker organizing desmin and actin in mouse hearts Daniel A. Hernandeza,†, Christina M. Bennetta,†, Lyubov Dunina-Barkovskayaa, Tatjana Wedigb, Yassemi Capetanakic, Harald Herrmannb,d, and Gloria M. Conovera,* aDepartment of Biochemistry & Biophysics, Texas A&M University, College Station, TX 77843-3474; bDivision of Molecular Genetics, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany; cCenter of Basic Research, Biomedi- cal Research Foundation Academy of Athens, Athens 11527, Greece; dInstitute of Neuropathology, University Hospital Erlangen, D-91054 Erlangen, Germany ABSTRACT In the hearts of patients bearing nebulette mutations, a severe general disorgani- Monitoring Editor zation in cardiomyocytes of the extrasarcomeric desmin intermediate filament system is fre- Robert D. Goldman quently observed. However, the molecular and functional relationship between the desmin Northwestern University cytoskeleton and nebulette-containing sarcomeres is still unclear. Here we report a high-affinity Received: Apr 18, 2016 in vitro interaction between nebulette and desmin filaments. A major interaction site has been Revised: Aug 31, 2016 mapped to the desmin α-helical rod domain, indicating that the filament core is directly in- Accepted: Oct 5, 2016 volved in the binding of nebulette. The disease-mutant desmin variants E245D and T453I ex- hibited increased binding affinity for nebulette, delayed filament assembly kinetics, and caused significant weakening of networks. In isolated chick cardiomyocytes and sections from canine heart, we revealed by ground-state depletion and confocal microscopies that module 5 of nebulette extends outward from Z-disk–associated desmin filaments toward the center of the sarcomere. Accordingly, in the myocardium of Des−/− mice, elevated levels of cardiac actin cor- related with alterations in the distribution of nebulette.
    [Show full text]
  • The Role of Z-Disc Proteins in Myopathy and Cardiomyopathy
    International Journal of Molecular Sciences Review The Role of Z-disc Proteins in Myopathy and Cardiomyopathy Kirsty Wadmore 1,†, Amar J. Azad 1,† and Katja Gehmlich 1,2,* 1 Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK; [email protected] (K.W.); [email protected] (A.J.A.) 2 Division of Cardiovascular Medicine, Radcliffe Department of Medicine and British Heart Foundation Centre of Research Excellence Oxford, University of Oxford, Oxford OX3 9DU, UK * Correspondence: [email protected]; Tel.: +44-121-414-8259 † These authors contributed equally. Abstract: The Z-disc acts as a protein-rich structure to tether thin filament in the contractile units, the sarcomeres, of striated muscle cells. Proteins found in the Z-disc are integral for maintaining the architecture of the sarcomere. They also enable it to function as a (bio-mechanical) signalling hub. Numerous proteins interact in the Z-disc to facilitate force transduction and intracellular signalling in both cardiac and skeletal muscle. This review will focus on six key Z-disc proteins: α-actinin 2, filamin C, myopalladin, myotilin, telethonin and Z-disc alternatively spliced PDZ-motif (ZASP), which have all been linked to myopathies and cardiomyopathies. We will summarise pathogenic variants identified in the six genes coding for these proteins and look at their involvement in myopathy and cardiomyopathy. Listing the Minor Allele Frequency (MAF) of these variants in the Genome Aggregation Database (GnomAD) version 3.1 will help to critically re-evaluate pathogenicity based on variant frequency in normal population cohorts.
    [Show full text]
  • Cellular Mechanisms of Muscle Fatigue
    PHYSIOLOGICAL REVIEWS Vol. ‘74, No. 1, January 1994 Printed in U.S.A. Cellular Mechanisms of Muscle Fatigue R. H. FITTS Department of Biology, Marquette University, Milwaukee, Wisconsin I. Introduction ......................................................................................... 49 A. Definition and current theories of fatigue ....................................................... 49 B. Muscle fiber type composition ................................................................... 50 C. Exercise intensity and environmental conditions ............................................... 51 II. Mechanical Properties ................................................................. .............. 51 A. Isometric contractile properties ................................................................. 52 B. Maximal shortening speed and peak power ..................................................... 55 III. Excitation-Contraction Coupling .................................................................... 55 A. Sarcolemma resting potential ................................................................... 55 B. Sarcolemma action potential .................................................................... 57 C. T tubular system ................................................................................. 58 D. T tubule-sarcoplasmic reticulum junction and calcium release from terminal cisternae ...... 60 IV. Lactic Acid, Intracellular pH, and Fatigue ......................................................... 62 A. Historical
    [Show full text]
  • List of Genes Associated with Sudden Cardiac Death (Scdgseta) Gene
    List of genes associated with sudden cardiac death (SCDgseta) mRNA expression in normal human heart Entrez_I Gene symbol Gene name Uniprot ID Uniprot name fromb D GTEx BioGPS SAGE c d e ATP-binding cassette subfamily B ABCB1 P08183 MDR1_HUMAN 5243 √ √ member 1 ATP-binding cassette subfamily C ABCC9 O60706 ABCC9_HUMAN 10060 √ √ member 9 ACE Angiotensin I–converting enzyme P12821 ACE_HUMAN 1636 √ √ ACE2 Angiotensin I–converting enzyme 2 Q9BYF1 ACE2_HUMAN 59272 √ √ Acetylcholinesterase (Cartwright ACHE P22303 ACES_HUMAN 43 √ √ blood group) ACTC1 Actin, alpha, cardiac muscle 1 P68032 ACTC_HUMAN 70 √ √ ACTN2 Actinin alpha 2 P35609 ACTN2_HUMAN 88 √ √ √ ACTN4 Actinin alpha 4 O43707 ACTN4_HUMAN 81 √ √ √ ADRA2B Adrenoceptor alpha 2B P18089 ADA2B_HUMAN 151 √ √ AGT Angiotensinogen P01019 ANGT_HUMAN 183 √ √ √ AGTR1 Angiotensin II receptor type 1 P30556 AGTR1_HUMAN 185 √ √ AGTR2 Angiotensin II receptor type 2 P50052 AGTR2_HUMAN 186 √ √ AKAP9 A-kinase anchoring protein 9 Q99996 AKAP9_HUMAN 10142 √ √ √ ANK2/ANKB/ANKYRI Ankyrin 2 Q01484 ANK2_HUMAN 287 √ √ √ N B ANKRD1 Ankyrin repeat domain 1 Q15327 ANKR1_HUMAN 27063 √ √ √ ANKRD9 Ankyrin repeat domain 9 Q96BM1 ANKR9_HUMAN 122416 √ √ ARHGAP24 Rho GTPase–activating protein 24 Q8N264 RHG24_HUMAN 83478 √ √ ATPase Na+/K+–transporting ATP1B1 P05026 AT1B1_HUMAN 481 √ √ √ subunit beta 1 ATPase sarcoplasmic/endoplasmic ATP2A2 P16615 AT2A2_HUMAN 488 √ √ √ reticulum Ca2+ transporting 2 AZIN1 Antizyme inhibitor 1 O14977 AZIN1_HUMAN 51582 √ √ √ UDP-GlcNAc: betaGal B3GNT7 beta-1,3-N-acetylglucosaminyltransfe Q8NFL0
    [Show full text]
  • Influence of Nebulin on the Assembly Mechanics Of
    INFLUENCE OF NEBULIN ON THE ASSEMBLY MECHANICS OF DESMIN An Undergraduate Research Scholars Thesis by MARC ADRIAN CARAGEA Submitted to Honors and Undergraduate Research Texas A&M University In partial fulfillment of the requirements for the designation as UNDERGRADUATE RESEARCH SCHOLAR Approved by Research Adviser: Gloria M. Conover, Ph.D. May 2014 Major: Biomedical Sciences TABLE OF CONTENTS Page ABSTRACT ............................................................................................................................... 1 ACKNOWLEDGMENTS ........................................................................................................... 2 NOMENCLATURE .................................................................................................................... 3 CHAPTER I INTRODUCTION ............................................................................................... 4 II MATERIALS AND METHODS ......................................................................... 8 Affinity purification of WT and mutant desmin proteins from bacteria ................ 8 Affinity purification of recombinant Nebulin M160 – 164 ................................... 9 Assembly protocol for desmin precursors into filaments in vitro ...................... 11 Sample preparation for atomic force microscopy ............................................... 11 Single desmin filament length acquisition and analysis ..................................... 13 Determination of Young’s modulus for desmin filament networks ...................
    [Show full text]
  • The Updated Training Wisdom of John Kellogg
    The Updated Training Wisdom of John Kellogg A collection of John Kellogg’s writings on training for distance runners Compiled by John Davis between May 2009 and December 2015 [email protected] www.runningwritings.com “Why do I pose as ‘Oz’? Because I know which mission to assign to help runners discover their potential. But I can't give them any results through magical powers; I'm just a human like the little carnival man from Kansas. I can only guide them. ” —John Kellogg Preface The goal of this project was to compile as many of John Kellogg’s posts on LetsRun.com as possible. I profoundly admire his training advice and his knowledge, and applying his principles to my own training brought me to new heights as a runner. Why John Kellogg, and not any of the other highly-regarded figures in the running world who have posted on LetsRun.com over the years (Renato Canova, Nobby Hashizume, Jack Daniels, et al.)? Perhaps because of his mysterious, guru-like reputation, or perhaps because of the sheer difficulty of assembling the range of posts. I also felt that it had to be done, that it would be a great loss for this knowledge to fade into obscurity over the years. John Kellogg seems to revel in the anonymity of the internet, and has posted under probably dozens of different “handles” over the years. In all likelihood, the writings here represent only a fraction of his total contribution to the online running community. Though his words sometimes fell on deaf ears, the power of the internet preserved much of his writing.
    [Show full text]
  • New Directions in Exercise Prescription: Is There a Role for Brain-Derived Parameters Obtained by Functional Near-Infrared Spectroscopy?
    brain sciences Perspective New Directions in Exercise Prescription: Is There a Role for Brain-Derived Parameters Obtained by Functional Near-Infrared Spectroscopy? Fabian Herold 1,2,* , Thomas Gronwald 3 , Felix Scholkmann 4,5, Hamoon Zohdi 5 , Dominik Wyser 4,6, Notger G. Müller 1,2,7 and Dennis Hamacher 8 1 Department of Neurology, Medical Faculty, Otto von Guericke University, Leipziger Str. 44, 39120 Magdeburg, Germany; [email protected] 2 Research Group Neuroprotection, German Center for Neurodegenerative Diseases (DZNE), Leipziger Str. 44, 39120 Magdeburg, Germany 3 Department Performance, Neuroscience, Therapy and Health, MSH Medical School Hamburg, University of Applied Sciences and Medical University, Am Kaiserkai 1, 20457 Hamburg, Germany; [email protected] 4 Department of Neonatology, Biomedical Optics Research Laboratory, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland; [email protected] (F.S.); [email protected] (D.W.) 5 Institute for Complementary and Integrative Medicine, University of Bern, 3012 Bern, Switzerland; [email protected] 6 ETH Zurich, Rehabilitation Engineering Laboratory, Department of Health Sciences and Technology, 8092 Zurich, Switzerland 7 Center for Behavioral Brain Sciences (CBBS), Universitätsplatz 2, 39106 Magdeburg, Germany 8 German University for Health and Sports, (DHGS), Vulkanstraße 1, 10367 Berlin, Germany; [email protected] * Correspondence: [email protected] Received: 29 April 2020; Accepted: 29 May 2020; Published: 3 June 2020 Abstract: In the literature, it is well established that regular physical exercise is a powerful strategy to promote brain health and to improve cognitive performance. However, exact knowledge about which exercise prescription would be optimal in the setting of exercise–cognition science is lacking.
    [Show full text]
  • (RSV) Infection? an Analysis Using the Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) RSV Database
    Does Ribavirin Impact on the Hospital Course of Children With Respiratory Syncytial Virus (RSV) Infection? An Analysis Using the Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) RSV Database Barbara J. Law, MD*; Elaine E. L. Wang, MDCM‡; Noni MacDonald, MD§; Jane McDonald, MDi; Simon Dobson, MD¶; Francois Boucher, MD#; Joanne Langley, MD**; Joan Robinson, MD‡‡; Ian Mitchell, MD§§; and Derek Stephens MSc‡ ABSTRACT. Objectives. To determine the relation- 20.6%, 20.9%, 15.5%, 15.2%, and 13.3%, respectively. ship between receipt of aerosolized ribavirin and the Across the subsets ribavirin use ranged from 36% to 57% hospital course of high-risk infants and children with of ventilated patients and 6% to 39% of nonventilated respiratory syncytial virus (RSV) lower respiratory infec- patients. For nonventilated patients in each subset the tion (LRI). median RSV-attributable hospital length of stay (RSV- Methods. The 1993–1994 Pediatric Investigators Col- LOS) was 2 to 3 days longer for ribavirin recipients and laborative Network on Infections in Canada (PICNIC) the duration of hypoxia was significantly increased. Du- RSV database consists of prospectively enrolled children ration of intensive care unit (ICU) stay was also increased with acute RSV LRI, admitted to nine Canadian pediatric for all ribavirin-treated subgroups except those with tertiary care centers. After excluding cases with compro- CHD. In contrast, for ventilated patients, ribavirin ther- mised immunity and/or nosocomial infection, subsets apy was
    [Show full text]
  • Anorexia/Cachexia Heart Failure Symptom Management Guideline for Adults, Age 19 and Older in British Columbia
    Anorexia/Cachexia Heart Failure Symptom Management Guideline For adults, age 19 and older in British Columbia What is anorexia? Anorexia is a syndrome characterized by some or all of the following symptoms: loss of appetite, nausea, early satiety, weakness, fatigue, food aversion, and significant physical and/or psychological symptoms. Causes of anorexia are multifactorial and include fatigue, dyspnea, medication side-effects, nausea, depression, anxiety and sodium restricted diets, which may all be found in patients with heart failure. What is cachexia? Cachexia is a syndrome characterized by severe body weight, fat and muscle loss and increased protein catabolism due to underlying disease. The prevalence of cachexia is 16–42% in the heart failure population and is associated with a 50%, 18 month mortality risk independent of variables such as ejection fraction, age and functional ability. How is cachexia diagnosed? Chronic condition with >5% weight loss in <12 months; or body mass index (BMI) <20kg/m2; and 3 out of 5 additional criteria: 1) Fatigue, 2) Decreased muscle strength, 3) Anorexia, 4) Low muscle mass, 5) Abnormal biochemistry *Blood testing to diagnose cachexia in advanced stages of disease is not advocated. Reminder: Malnutrition also affects prognosis in patients with heart failure and is often found in early transitions of the disease. However this symptom management guideline will focus on the assessment and treatment of anorexia and cachexia. Approach to Managing Anorexia/Cachexia Assessment History: When did weight loss begin? How much weight was lost? Obtain baseline (dry) weight. How is [the patients] appetite? What do they eat or drink on a typical day? How has weight loss affected mood? Ask about: nausea, early satiety, dyspnea, poor oral hygiene, dysphagia, malabsorption, bowel habits.
    [Show full text]
  • The Medical Management of Fibrodysplasia Ossificans Progressiva: Current Treatment Considerations
    THE MEDICAL MANAGEMENT OF FIBRODYSPLASIA OSSIFICANS PROGRESSIVA: CURRENT TREATMENT CONSIDERATIONS The International Clinical Consortium on Fibrodysplasia Ossificans Progressiva1 May 2011 From The Center for Research in FOP and Related Disorders, The University of Pennsylvania School of Medicine, Philadelphia, PA 19104 Corresponding Editor: Frederick S. Kaplan, M.D. Isaac and Rose Nassau Professor of Orthopaedic Molecular Medicine Director, Center for Research in FOP & Related Disorders The Perelman School of Medicine - The University of Pennsylvania Department of Orthopaedic Surgery 3737 Market Street – Sixth Floor Philadelphia, PA 19104, USA Tel: (office) 215-294-9145 Fax: 215-222-8854 Email: [email protected] Reprint Requests: [email protected] Associate Editors: Eileen M. Shore, Ph.D. Robert J. Pignolo, M.D., Ph.D. [Kaplan FS, Shore EM, Pignolo RJ (eds), name of individual consortium member, and The International Clinical Consortium on FOP. The medical management of fibrodysplasia ossificans progressiva: current treatment considerations. Clin Proc Intl Clin Consort FOP 4:1-100, 2011] 1See Section X (pages 84-100) for Complete Author Listing. ` 1 ABSTRACT…………………………………………………………………………………………… 5 I. THE CLINICAL AND BASIC SCIENCE BACKGROUND OF FOP……………..…………….. 6 A. Introduction………………………………………………………………..…..…..…………………. 6 B. Classic Clinical Features of FOP……………………………………………………..……………. 6 C. Other Skeletal Anomalies in FOP…………………………………………………………… 6 D. Radiographic Features of FOP……………………………………………………….…….... 7 E. Histopathology of FOP Lesions………………………………………………………………. 7 F. Laboratory Findings in FOP………………………………………………………………… 8 G. The Immune System & FOP…………………………………………………………………. 8 H. Misdiagnosis of FOP………………………………………………………………………………… 8 I. Epidemiologic, Genetic & Environmental Factors in FOP……………………..…………. 9 J. FOP & the BMP Signaling Pathway………………………………………………………… 9 K. The FOP Gene………………………………………………………………..………………. 9 L. Structural and Functional Consequences of the FOP Mutation…………………………… 10 M.
    [Show full text]
  • Age-Specific Modulation of Intermuscular Beta Coherence
    www.nature.com/scientificreports OPEN Age‑specifc modulation of intermuscular beta coherence during gait before and after experimentally induced fatigue Paulo Cezar Rocha dos Santos1,2,5*, Claudine J. C. Lamoth1, Fabio Augusto Barbieri3, Inge Zijdewind4, Lilian Teresa Bucken Gobbi2 & Tibor Hortobágyi1 We examined the efects of age on intermuscular beta‑band (15–35 Hz) coherence during treadmill walking before and after experimentally induced fatigue. Older (n = 12) and younger (n = 12) adults walked on a treadmill at 1.2 m/s for 3 min before and after repetitive sit‑to‑stand, rSTS, to induce muscle fatigability. We measured stride outcomes and coherence from 100 steps in the dominant leg for the synergistic (biceps femoris (BF)‑semitendinosus, rectus femoris (RF)‑vastus lateralis (VL), gastrocnemius lateralis (GL)‑Soleus (SL), tibialis anterior (TA)‑peroneus longus (PL)) and for the antagonistic (RF‑BF and TA‑GL) muscle pairs at late swing and early stance. Older vs. younger adults had 43–62% lower GL‑SL, RF‑VL coherence in swing and TA‑PL and RF‑VL coherence in stance. After rSTS, RF‑BF coherence in late swing decreased by ~ 20% and TA‑PL increased by 16% independent of age (p = 0.02). Also, GL‑SL coherence decreased by ~ 23% and increased by ~ 23% in younger and older, respectively. Age afects the oscillatory coupling between synergistic muscle pairs, delivered presumably via corticospinal tracts, during treadmill walking. Muscle fatigability elicits age‑specifc changes in the common fuctuations in muscle activity, which could be interpreted as a compensation for muscle fatigability to maintain gait performance. Healthy aging modifes the integrated and coordinated neural control of gait1,2.
    [Show full text]
  • Spinal and Bulbar Muscular Atrophy
    Spinal and bulbar muscular atrophy Description Spinal and bulbar muscular atrophy, also known as Kennedy disease, is a disorder of specialized nerve cells that control muscle movement (motor neurons). These nerve cells originate in the spinal cord and the part of the brain that is connected to the spinal cord (the brainstem). Spinal and bulbar muscular atrophy mainly affects males and is characterized by muscle weakness and wasting (atrophy) that usually begins in adulthood and worsens slowly over time. Muscle wasting in the arms and legs results in cramping; leg muscle weakness can also lead to difficulty walking and a tendency to fall. Certain muscles in the face and throat (bulbar muscles) are also affected, which causes progressive problems with swallowing and speech. Additionally, muscle twitches (fasciculations) are common. Some males with the disorder experience unusual breast development ( gynecomastia) and may be unable to father a child (infertile). Frequency This condition affects fewer than 1 in 150,000 males and is very rare in females. Causes Spinal and bulbar muscular atrophy results from a particular type of mutation in the AR gene. This gene provides instructions for making a protein called an androgen receptor. This receptor attaches (binds) to a class of hormones called androgens, which are involved in male sexual development. Androgens and androgen receptors also have other important functions in both males and females, such as regulating hair growth and sex drive. The AR gene mutation that causes spinal and bulbar muscular atrophy is the abnormal expansion of a DNA segment called a CAG triplet repeat. Normally, this DNA segment is repeated up to about 36 times.
    [Show full text]